Approval of medicines

Requests for Norway as RMS in the assessment of human medicinal products in the Decentralised Procedure – 2026

The Nordic language pilot marks one year and continues to expand

EU agrees on new pharmaceutical legislation

Status of the Transition to the New Case-Processing Platform for Marketing Authorisations